Williams & Connolly Named Hatch-Waxman Litigation Firm of the Year – Branded by LMG Life Sciences

October 2021

On Wednesday, September 22nd, Williams & Connolly was honored with two awards at the 2021 LMG Life Sciences awards dinner in New York City.  LMG recognized Williams & Connolly as the Hatch-Waxman Litigation Firm of the Year – Branded, and awarded the Hatch-Waxman Impact Case of the Year for the firm’s representation of AstraZeneca in closely-watched patent litigation in the Northern District of West Virginia concerning AstraZeneca’s blockbuster Symbicort product, an inhaler treatment for asthma.  The team representing AstraZeneca includes David Berl, Jessica Rydstrom, Jessica Ryen, and Kevin Hoagland-Hanson.

In addition to these awards, LMG Life Sciences has recognized Williams & Connolly as “highly recommended” in General Patent Litigation, Hatch-Waxman Patent Litigation (Branded), and Product Liability, and has named the following eleven partners to the list of “Life Science Stars” in the practice areas noted below:
Intellectual Property
Non-IP Litigation and Enforcement
Please click here to see a full list of the 2021 LMG Life Sciences Award winners.
Click here to see the 2021 LMG Life Sciences rankings


back to top